$PGNY News

Progyny: Slow But Consistent Growth With A Pristine Balance Sheet

Progyny, Inc. to Present at the Wells Fargo Healthcare Conference

Progyny (NASDAQ:PGNY): An Affordable Growth Stock With Strong Earnings and Reasonable Valuation

Wells Fargo Conceives a High Rating for the Fertility-Benefits Biz

JP Morgan Maintains Neutral on Progyny, Raises Price Target to $30

Wells Fargo Initiates Coverage On Progyny with Overweight Rating, Announces Price Target of $37

Progyny (NASDAQ:PGNY): A Decent Value Stock Combining Reasonable Valuation and Solid Fundamentals

Progyny Sees Utilization Rebound as Early Renewals De-Risk Outlook

The 5 Most Interesting Analyst Questions From Progyny’s Q2 Earnings Call

Progyny (PGNY) Q2 2026 Earnings Call Transcript

Truist Securities Maintains Buy on Progyny, Raises Price Target to $36

Barclays Maintains Equal-Weight on Progyny, Lowers Price Target to $30

Why Progyny (PGNY) Shares Are Sliding Today

Progyny (PGNY) Stock May Still Trade At A Discount As Earnings Hold Up

PGNY Q2 CY2026 Deep Dive: Seasonality and Guidance Weigh on Positive Underlying Performance

Why Progyny Stock Plunged, Then Gradually Recovered Today

Progyny, Inc. to Present at the Canaccord Genuity Annual Growth Conference

Progyny, Inc. Q2 2026 Earnings Call Summary

Progyny Q2 Earnings Call Highlights

Progyny, Inc. 2026 Q2 - Results - Earnings Call Presentation